欢迎大家加入快乐学习小组！

一、发表的部分SCI文章情况：

1. Zou HB, Chen Y*, Duan ZP*, Zhang H. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. PloS ONE, 2011;6(10): e26748.

2. Zou HB, Chen Y, Duan ZP, Zhang H, Pan CQ*. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-Positive mothers. J Viral Hepat, 2012,19(2): e18-e25

3. Pan CQ*, Duan ZP, Bhamidimarri KR, Zou HB, Liang XF, Li J, Tong MJ. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012,10(5):452-459.

4. Pan CQ, Zou HB#, Chen Y, Zhang XH, Zhang H, Li J, Duan ZP*.Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. Clin Gastroenterol Hepatol. 2013 ,11(10):1349-1358（共第一）

5.Li JF,Liu S#,Ren F, Liu M, Wu HL, Chen Y, Zou HB, Bai L, Li Y, Zheng SJ*, Duan ZP*. Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study,Int J Infect Dis,2014,27:49-53.

6. Pan CQ*, Duan ZP, Dai EH, Zhang SQ, Han GR, Wang YM, Zhang H, Zou HB, Zhu BS, Zhao WJ, Jiang HX. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. N Engl J Med. 2016, 374(24): 2324-2334.

7.Zhao MY, Zou HB#, Chen Y, Zheng SJ, Duan ZP*. Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus. J Viral Hepat. 2019,26(9):1059-1065.（共第一）

8. Li L, Zou HB#, XU MM, Li S, Zhu YX, Zheng SJ, Duan ZP, Chen Y*. Risk factors related to postpartum hepatic inflammation in pregnant women with chronic hepatitis B. J Int Med Res,2020,48(11):300060520966439.（共第一）

9.Xiao YW, Sun KX#, Duan ZP, Liu ZX, Li Y, Yan L, Song YR, Zou HB, Zhuang H, Wang J, Li J*. Quasispecies characteristic in "a" determinant region is a potential predictor for the risk of immunoprophylaxis failure of mother-to-child-transmission of sub-genotype C2 hepatitis B virus: a prospective nested case-control study.Gut,2020 ,69(5):933-941.

10. Li LY, Liu ZX#, Song YR, Xiao YW, JiangJ, Li LL,Zhai XJ, Liu jX, Duan ZP, Ding F, Liu J, 

Zhuang H, Zhu LG, Jiang J, Zou HB, Jie Wang J, Li J*. Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study. Emerg Microbes Infect, 2020,9(1):1881-1891.

11.Bai J, Li L#, Liu H, Liu S, Bai L, Ning HB, Song WY, Zou HB, Wang XX, Chen Y, Zheng SJ*, 

Duan ZP*.A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report. Ann Transl Med,2021,9(5):426.

12. Zhang XH, Zou HB#, ChenY, Zhang H, Tian  RH, Meng J, Zhu YX, Guo HM, Dai EH, Zhu BS, Liu ZS, Jin YX, Li YJ, Feng LP, Zhuang H, Pan CQ*, Li J*, Duan ZP*. The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: a prospective, multicenter, large-sample cohort study.BMC Medicine, 2021,19(1):148. （共第一）

13.Xu MM, Kong M#, Yu PF, Cao YY, Liu F, Zhu B, Zhang YZ, Lu W, Zou HB, Duan BW, You SL, Xin SJ, Han T*, Duan ZP*, Chen Y*. Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study. J Clin Transl Hepatol, 2021, 9(5):626-634.

14.LuY, Song YR#, Zhai XJ, Zhu FC, LiuJX, Chang ZJ, Li Y, Xiao YW, Li LL, Liu MM, Liu J, Duan ZP, Zou HB, Zhuang H*, Wang J*, Li J*. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus. Emerg Microbes Infect,2021,10(1):555-564.

15.Li Y, Xiao YW, Li LL, Song YR, Zhai XJ, Liu JX, Duan ZP, Yan L, Ding F, Liu J, Zhu LG, Jiang J, Zou HB, Li LX, Liang CH, Wang J*, Li J*. The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study.Virol J,2021,18(1):236

16.Xu MM, Kong M#, Yu PF, Cao YY, Liu F, Zhu B, Zhang YZ, Lu W, Zou HB, , YouSL, Xin SJ, Duan ZP*,Han T*,  Chen Y*.Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis. Front Med (Lausanne),2021,8:750061.

17.PanCQ*, Dai EH, Duan ZP, Han GR, Zhao WJ, Wang YM, Zhang H, Zhu BS, Jiang HX, ZhangSQ, Zhang XH, Zou HB, Chen XL, Chen Y. Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China. Gut,2022,71(4):798-806.

18. Li L, Xu M, Zou H, Liu S, Zheng S, Duan Z, Zhu Y, Chen Y. Meta-Analysis of the Risk for Abnormal Liver Function in Pregnancy with High HBV DNA After Antiviral Therapy Withdrawal. Altern Ther Health Med. 2023,29(1):280-288

19.Li Y, Li L, Song Y, Liu M, Zhai X, Duan Z, Ding F, Zhu L, Jiang J, Zou H, Wang J, Li J. Booster Vaccination in Infancy Reduces the Incidence of Occult HBV Infection in Maternal HBsAg-positive Children. J Clin Transl Hepatol. 2023 ,11(3):661-669.

20.Tian Y, Fan Z, Zhang X, Xu L, Cao Y, Pan Z, Mo Y, Gao Y, Zheng S, Huang J, Zou H, Duan Z, Li H, Ren F. CRISPR/Cas13a-Assisted accurate and portable hepatitis D virus RNA detection. Emerg Microbes Infect. 2023,12(2):227633.

21.Yang J, Zhao T, Fan J, Zou H, Lan G, Guo F, Shi Y, Ke H, Yu H, Yue Z, Wang X, Bai Y, Li S, Liu Y, Wang X, Chen Y, Li Y, Lei X. Structure-guided discovery of bile acid derivatives for treating liver diseases without causing itch. Cell. 2024 Dec 12;187(25):7164-7182.e18.（共第一）

22.Pan CQ, Dai E, Mo Z, Zhang H, Zheng TQ, Wang Y, Liu Y, Chen T, Li S, Yang C, Wu J, Chen X, Zou HB, Mei S, Zhu L. Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial. JAMA. 2025,333(5):390-399.

23. Zou H, Zhu L, Cao L, Suo S, Zhu Y, Wang Y, Dong J, Han B, Duan Z, Chen Y, Pan CQ. Vertical Transmission in Mothers Taking TAF With Exceptionally High Viral Load. J Viral Hepat. 2025 Mar;32(3):e70000.

24.Zhang HB, Zou HB, Gao YY, Wang L, Gao Y, Kong M, Kang WW, Zhong R, Yang XS, Ren Y, Feng LL, Li L, Li S, Duan ZP, Zhan YT, Chen Y.An Open-Label Randomized Controlled Non-Inferiority Trial of Arginine Glutamate Injection for the Treatment of Mild Hepatic Encephalopathy.J Dig Dis. 2025 May;26(5-6):241-249.（共同第一）

25.Cui L, Zou H, You S, Guo C, Gu J, Shang Y, Jia G, Zheng L, Deng J, Wang X, Sun R, Ding D, Wang W, Zhou X, Guo G, Liu Y, Han Z, Han Z, Chen Y, Han Y.Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial.Chin Med J (Engl). 2025 Sep 20;138(18):2347-2349.（共同第一）

二、代表性论著

1.《疑难及重症肝病临床诊疗100例》，天津科学技术出版社，秘书兼编委

2.《疑难及重症肝病查房实录》，中国医药科技出版社，编委

3.《现代肝胆病学》，科学出版社，编委

三、发明专利

1.一种新型多性能引流管，实用新型专利，专利授权号：ZL 2022 2 2538230.6

四、科研获奖情况：

乙肝病毒母婴阻断关键技术与应用，北京市科学技术进步 二等奖，2020年12月

五、国际获奖情况：

HepaCure治疗慢加急性肝衰竭的I期临床试验研究，美国肝病研究学会（AASLD）临床/转化科学青年研究者奖，2025年11月。